Calcium dobesilate reduces oxidative stress in cardiac surgery

Journal of Cardiovascular Surgery

Volumn 50, Issue 5, 2009, Pages 695-701

  Cerrahoglu, M ^a   Taner Kurdal, A ^a   Iskesen, I ^a   Onur, E ^a   Sirin, H ^a  

^a CELAL BAYAR UNIVERSITY   (Turkey)

Author keywords

Antioxidants; Calcium dobesilate; Free radicals; Ischemia; Reperfusion

Indexed keywords

DOBESILATE CALCIUM; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; MYOGLOBIN; SUPEROXIDE DISMUTASE; TROPONIN T;

ANTIOXIDANT ACTIVITY; AORTA CLAMPING; ARTICLE; BLOOD ANALYSIS; CARDIOPLEGIA; CARDIOPULMONARY BYPASS; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ENZYME BLOOD LEVEL; ENZYME RELEASE; FEMALE; HEART FUNCTION; HEART MUSCLE INJURY; HEART MUSCLE ISCHEMIA; HUMAN; MALE; OXIDATIVE STRESS; PREMEDICATION; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; REPERFUSION INJURY; SCAVENGING SYSTEM;

BIOLOGICAL MARKERS; CALCIUM DOBESILATE; CARDIOPULMONARY BYPASS; CORONARY ARTERY BYPASS; DOUBLE-BLIND METHOD; FEMALE; FREE RADICAL SCAVENGERS; GLUTATHIONE PEROXIDASE; HEMODYNAMICS; HUMANS; MALE; MALONDIALDEHYDE; MIDDLE AGED; MYOCARDIAL REPERFUSION INJURY; MYOGLOBIN; OXIDATIVE STRESS; PROSPECTIVE STUDIES; SUPEROXIDE DISMUTASE; TIME FACTORS; TREATMENT OUTCOME; TROPONIN T;

EID: 70949084505     PISSN: 00219509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Maxwell SR, Lip GY. Reperfusion injury: A review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol 1997;58:95-117.
2. Dhalla NS, Elmoselhi AB, Hata T, Makino N. Status of myocardial antioxidants in ischemia-reperfusion injury. Cardiovasc Res 2000;7:446-456
3. Wattanapitayakul SK, Bauer JA. Oxidative pathways in cardiovascular disease: roles, mechanisms, and therapeutic implications. Pharmacol Ther 2001;89:187-206.
4. Hannaert P, Brunet J, Farine JC, Garay RP. Antioxidant-angioprotective actions of calcium dobesilate in diabetic rats. Int J Angiol 1999;8:2-4.
5. Iskesen I, Sarbulbul O, Cerrahoglu M, Onur E, Tekin C, Sirin H. Cardioproteaive effea of calcium dobesilate during open-heart surgery. Aaa Cardiol 2006;61:69-74. (Pubitemid 43198503)
6. Pares-Herbute N, Fliche E, Monnier L. Involvement of nitric oxide in the inhibition of aortic smooth muscle cell proliferation by calcium dobesilate. Int J Angiol 1999;8:5-10.
7. Sun Y, Oberley LW, Ying L. A simple method for clinical assay of superoxide dismutase. Clin Chem 1988;34:497-500. (Pubitemid 18102175)
8. Durak I, Yurtaslan Z, Canbolat O, Akyol O. A methodological approach to SOD aaivity assay based on inhibition of nitroblue tetrazolium (NBT) reduaion. Clin Chim Acta 1993;214:103-104
9. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95:351-8.
10. Khan TA, Bianchi C, Voisine P, Feng J, Baker J, Hart M et al. Reduction of myocardial reperfusion injury by aprotinin after regional ischemia and cardioplegic arrest. J Thorac Cardiovasc Surg 2004;128:602-608 (Pubitemid 39278395)
11. Tanriverdi H, Evrengul H, Kuru O, Tanriverdi S, Seleci D, Enli Y. Cigarette smoking induced oxidative stress may impair endothelial funaion and coronary blood flow in angiographically normal coronary arteries. Circ J 2006;70:593-599
12. Folden DV, Gupta A, Sharma AC, Li SY, Saari JT, Ren J. Malondialdehyde inhibits cardiac contractile funaion in ventricular myocytes via a p38 mitogen-aaivated protein kinase-dependent mechanism. Br J Pharmacol 2003;139:1310-1316 (Pubitemid 37026414)
13. Chen Z, Oberley TD, Ho Y, Chua CC, Siu B, Hamdy RC et al. Overexpression of CuZnSOD in coronary vascular cells attenuates myocardial ischemia/reperfusion injury. Free Radic Biol Med 2000;29:589-596 (Pubitemid 30738589)
14. Haramaki N, Stewart DB, Aggarwal S, Ikeda H, Reznick AZ, Pocker L. Networking antioxidants in the isolated rat heart are selectively depleted by ischemia-reperfusion. Free Radic Biol Med 1998;25:329-339 (Pubitemid 28326208)
15. Temsah RM, Netticadan T, Chapman D, Takeda S, Mochizuki S, Dhalla NS. Alterations in sarcoplasmic reticulum function and gene expression in ischemic-reperfused rat heart. Am J Physiol 1999;277:584-594
16. Tossios P, Bloch W, Huebner A, Raji MR, Dodos F, Klass O et al. N-acetylcysteine prevents reactive oxygen species-mediated myocardial stress in patients undergoing cardiac surgery: Results of a randomized, double-blind, placebo-controlled clinical trial. J Thorac Cardiovasc Surg 2003;126:1513-1520 (Pubitemid 37449181)
17. Shiomi T, Tsutsui H, Matsusaka H, Murakami K, Hayashidani S, Ikeuchi M et al. Overexpression of glutathione peroxidase prevents left ventricular remodeling and failure after myocardial infarction in mice. Circulation 2004;109:544-549 (Pubitemid 38168520)
18. Leite E, Mota M, Faria de Abreu J, Cunha-Vaz J. Effea ofcalcium dobesilate on the blood-retinal barrier in early diabetic retinopathy. Int Ophthalmol 1990;14:81-88 (Pubitemid 20197614)
19. Hachen H, Hachen FICA, Lorenz P. Etude clinique and plé thysmographique en double-aveugle du Dobésilate de Calcium chez des patientes atteintes de troubles microcirculatoires périphériques. Angiologie 1982;33:480-487
20. Widmer L, Biland L, Barras JP. Doxiumw 500 dans le traitement de l'insuffisance veineuse chronique: étude multicentre en double aveugle contre placebo. Int Angiol 1990;9:105-110
21. Ruiz E, Lorente R, Tejerina T. Effects of calcium dobesilate on the synthesis of endothelium-dependent relaxing faaors in rabbit isolated aorta. Br J Pharmacol 1997;121:711-716 (Pubitemid 27260774)
22. Bijsterveld J, Janssen PT. The effea of calcium dobesilate on albumin leakage of the conjunctival vessels. Curr Eye Res 1981;1:425-430
23. Vojnikovic, B. Doxium® (calcium dobesilate) reduces blood hyperviscosity and intraocular pressure in patients with diabetic retinopathy and glaucoma. Ophthalmol Res 1991;23:12-20.
24. Michal M, Gotti C. Effea of calcium dobesilate on platelet function. Thromb Res 1998;51:593-605.
25. Michal M, Giessinger N. Effea of calcium dobesilate and its interaction with aspirin on thrombus formation in vivo. Thromb Res 1985;40:215-226 (Pubitemid 16177152)
26. Brunet J, Farine JC, Garay RP, Hannaert P. Angioproteaive action of calcium dobesilate against reactive oxygen species-induced capillary permeability in the rat. Eur J Pharma 1998;358:213-220 (Pubitemid 28498181)
27. Schram MT, Stam F, DeJongh RT, DeVries G, VanDijk R, Serne EH et al. The effect of calcium dobesilate on vascular endothelial function, blood pressure, and markers of oxidation in obese male smokers: a placebo-controlled randomised clinical trial. Atherosclerosis 2004;170:59-72. (Pubitemid 37083564)
28. Graber R, Farine JC, Losa GA. Calcium dobesilate proteas human peripheral blood mononuklear cells from oxidation and apoptosis. Apoptosis 1998;3:41-49 (Pubitemid 128512004)
29. Benarroch IS, Brodsky M, Rubinstein A, Viggiano C, Salama EA. Treatment of blood hyperviscosity with calcium dobesilate in patients with diabetic retinopathy. Ophthalmic Res 1985;17:131-138 (Pubitemid 15116162)
30. Beyer J, Meissner KO, Happ J, Cordes U. Wirkung von Calciumdobesilat auf die Permeation von Plasmaprotein beim Diabetiker. Dtsch Med Wochenschr 1980;105:1604-1608 (Pubitemid 10029811)
31. Tamas P, Csermely T, Ertl T, Vizer M, Szabo I, Prievara FT. Calcium dobesilate lowers the blood pressure in mild to moderate midtrimester hypertension: a pilot study. Gynecol Obstet Invest 1999;47:210-213 (Pubitemid 29145728)